NITRIC oxide (NO) is becoming recognized as an import ant intercellular messenger in the brain. The present experiment used microdialysis to examine the potential role of NO in the regulation of dopamine (DA) and sero tonin (5-HT) release in the medial preoptic area (MPOA) of freely moving male rats. The NO precursor L-arginine (L-Arg, 100 fLM), administered into the MPOA via the dialysis probe, increased extracellular levels of DA, 5-HT, and the major metabolites of DA. These increases were blocked by the coadministration of the NO synthase inhibitor N-monomethyl L-arginine (NMMA, 400 fLM). The inactive isomer D-arginine (100 fLM) was ineffective, and NMMA by itself decreased DA below baseline levels. Thus, NO may modulate the release of DA and 5-HT in the MPOA.
Introduction
Nitric oxide (NO), originally recognized as a vaso dilator released from vascular endothelial cells,l,2 was subsequently discovered to be a neuronal messenger. 3 NO is a highly reactive gas, produced by the action of NO synthase on L-arginine (L-Arg) in a Ca 2 + depen dent fashion. In the brain NO has been implicated in long term potentiation,410ng term depression,s and the development of functional cortical maps.6 NO has also been reported to increase the release of several neuro transmitters, including dopamine (DA) from striatal slices,l-9 norepinephrine (NE) and acetylcholine (ACh) from hippocampal slices,'o glutamate and aspartate from the medulla,'1 and ACh from basal forebrainY
The medial preoptic area (MPOA) is important for the regulation of temperature, male sexual behavior, and maternal behavior. 13-15 Large fibers containing NO synthase are scattered through the MPOA. 16 Further more, endogenously formed NO may mediate the hyperthermic effects of prostaglandin in the MPOA. 17 The present study evaluated the potential role of NO in the regulation of DA and serotonin (S-HT) rel ease in the MPOA of conscious, freely moving rats. The precursor of NO, L-arginine (L-Arg), its inactive isomer, D-arginine (D-Arg), and/or an inhibitor of its synthesis, N-monomethyl L-arginine (NMMA), were perfused into the brain through a micro dialysis mem brane, while DA, S-HT, and their metabolites diffused into the dialysate and were assayed using high per formance liquid chromatography with electrochemical detection (HPLC-EC).
Materials and Methods
Twenty-three adult male Long~Evans rats (Harlan Sprague~Dawley/Blue Spruce), weighing 300~37S g, Food and water were available ad libitum. The animals were anesthetized with ketamine hydrochloride (SO mg kg-1) and xylazine hydrochloride (4 mg kg-I). Each animal received a 21 ga stainless steel guide can nula, ending above the left MPOA (AP, +2.4; ML, +0.2; DV, ~7.0; incisor bar, +S mm). Details of the surgery and cannula construction are described in reference 18. A 2S0 J..Ll centrifuge tube with the end cut off (approxi mate length 8 mm) was imbedded in the dental cement around the guide cannula to provide a seat for the microdialysis probe. An obturator fashioned from 26 ga stainless steel tubing was inserted though a cen trifuge tube cap and was cut to end even with the guide cannula.
Microdialysis probes using a concentric flow design were made according to the procedure in reference 19. A length of silicon capillary tubing (ISO J..Lm o.d.) was inserted into a 17 mm 26 ga stainless steel tube extend ing approximately 1 mm beyond the tip of the stainless steel tube. A hollow fiber dialysis membrane (MW cut off, 6000; 210 J..Lm o.d.; Spectra-Por) was fitted over the silicon capillary tube and glued to the tip of the stain less steel tube. The length of the dialysis membrane was cut to 1.S mm and plugged with waterproof epoxy. The active dialyzing surface of the membrane was 1 mm. Perfusion medium flowed in through the stainless steel tubing, and out via the silicon capillary tube, sur rounded by medline tubing, into a 2S0 J..Ll centrifuge tube. In vitro recovery averaged 30% at the rate of flow used in these experiments.
The dialysis perfusion medium was a modified Dul becco's phosphate buffered saline solution (Sigma) (138 mM NaCI, 2. On the day of testing, the animal was briefly anesthe tized with ketamine hydrochloride (25 mg kg-I) and xylazine hydrochloride (2 mg kg-I) to allow removal of the obturator and insertion of the probe. The flow of perfusion medium was started immediately after probe insertion, and a 2 h stabilization period occurred prior to sample collection. Baseline samples were collected until three consecutive samples showed no more than 10% variation in levels. At this time the injection syr inge was exchanged for one containing the appropriate drug dissolved in Dulbecco's solution, and three samples were collected during drug infusion. Sixteen animals received the NO precursor L-Arg (100 IJ.M); half of these also received the inactive isomer D-Arg (100 IJ.M) for three samples before L-Arg adminis tration. The remaining seven animals received the NO synthesis inhibitor NMMA (400 IJ.M); four of these also received NMMA plus L-Arg (100 IJ.M) following NMMA alone. At the conclusion of the experiment, subjects were sacrificed, the brains were frozen, and the probe placements were histologically verified.
Samples were assayed for the parent amines DA and 5-HT and their metabolites 3,4-dihydroxyphenyla cetic acid (DOPAC), homovanillic acid (HVA), and 5-hydroxyindoleacetic acid (5-HIAA) using HPLC-EC. Compounds were separated in a BAS Sep Stik microbore column, using a mobile phase consist ing of 32 mM citric acid, 54. and 3% methanol (pH, 4.1). A Gilson model 307 pump, equipped with a flow splitter and three pulse dampers, operated at a flow rate of 0.62 ml min-I. Compounds were detected with a BAS LC-4B ampe rometric detector (sensitivity, 0.5 nA/V), using a glassy carbon electrode maintained at a potential of +0.7 V relative to a AgiAgCl reference electrode. The limit of detectability (3 x background) was 0.5 ng 5 1J.1-1 •
The data are expressed as a percentage of the final baseline sample preceding the drug treatment. Separate analyses of variance (ANOVAs) were run for the two groups of animals, followed by Duncan's post hoccom parisons. The first ANOVA compared baseline, the first D-Arg, and the first L-Arg samples; the second compared baseline, the first NMMA, and the first NMMA+L-Arg samples. All animals had probes cor rectly placed in the MPOA. 
Ivnnc oXlOe Increases rransmtrrer release
gesting that endogenous levels of NO may promote DA release.
Discussion
L-Arg, the precursor of NO, stereospecifically increased the release of DA and its major metabolites and also enhanced the release of 5-HT. In addition, the NO synthase inhibitor NMMA inhibited the basal rel ease of DA and abolished the facilitation by L-Arg. These data suggest that endogenously formed NO may facilitate the release of these monoamines. A likely rea son that NMMA+L-Arg produced slightly more inhi bition than did NMMA alone is that the combination was always given after NMMA alone. Thus, there was a progressive inhibition of NO synthesis over time. Fur thermore, the synthesis inhibitor was four times as concentrated as the precursor, so that L-Arg would have little chance to increase NO synthesis.
The means by which NO influences transmitter rel ease is not clear. Because NO synthase is located in scattered large fibers in the MPOA,!6 it may elicit the release of transmitter(s) from those same fibers, or, since NO readily permeates cell membranes, it may affect release from nearby terminals. Activation of gua nylate cyclase appears to mediate NO's enhancement of excitatory amino acid release in the medulla;!! how ever, neither activation of guanylate cyclase nor block ade of electron transport was implicated in its induction of Ca 2 +-dependent DA release from striatal slices. s DA activity in the MPOA is increased during copu lation in male rats. 20 ,2! Furthermore, stimulation of DA receptors in the MPOA facilitates copulation,!8 ex cop ula genital reflexes,22,23 and sexual motivation. 24 In addition, 5-HT levels are increased in tissue punches of male rats following ejaculation, and may contribute to the postejaculatory period of quiescence. 25 Thus, one function of NO in the MPOA may be to modulate the prolonged DA release that accompanies and facilitates copulation and to elicit the release of 5-HT at ejaculation. 
Conclusion
Administration of L-Arg, the precursor of NO, into the MPOA of male rats increased extracellular levels of DA and its major metabolites, as well as 5-HT. The inactive isomer was ineffective. The NO synthase inhibitor NMMA decreased basal levels of extracellu lar DA and blocked the ability of L-Arg to increase rel ease. Thus, endogenously formed NO may enhance the release of neurotransmitters in the MPOA, which have been implicated in the control of male sexual behavior and of temperature regulation.
